Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$1.43 - $3.14 $150,007 - $329,386
104,900 Added 82.53%
232,000 $469,000
Q4 2021

Feb 15, 2022

SELL
$2.7 - $4.76 $44,550 - $78,540
-16,500 Reduced 11.49%
127,100 $344,000
Q3 2021

Nov 16, 2021

SELL
$4.06 - $5.8 $196,097 - $280,140
-48,300 Reduced 25.17%
143,600 $640,000
Q2 2021

Aug 16, 2021

BUY
$5.02 - $7.05 $3,513 - $4,935
700 Added 0.37%
191,900 $1.11 Million
Q1 2021

May 18, 2021

BUY
$4.81 - $10.34 $350,168 - $752,752
72,800 Added 61.49%
191,200 $1.34 Million
Q4 2020

Feb 17, 2021

SELL
$4.13 - $6.41 $89,621 - $139,097
-21,700 Reduced 15.49%
118,400 $568,000
Q3 2020

Nov 17, 2020

SELL
$4.82 - $7.72 $87,242 - $139,732
-18,100 Reduced 11.44%
140,100 $817,000
Q2 2020

Aug 17, 2020

BUY
$5.69 - $9.69 $650,367 - $1.11 Million
114,300 Added 260.36%
158,200 $1.07 Million
Q1 2020

May 15, 2020

SELL
$3.77 - $11.0 $8,671 - $25,300
-2,300 Reduced 4.98%
43,900 $279,000
Q4 2019

Feb 14, 2020

BUY
$3.0 - $16.43 $59,100 - $323,671
19,700 Added 74.34%
46,200 $482,000
Q1 2019

May 16, 2019

BUY
$17.66 - $30.28 $134,216 - $230,128
7,600 Added 40.21%
26,500 $658,000
Q2 2018

Aug 15, 2018

BUY
$42.06 - $62.4 $323,862 - $480,480
7,700 Added 68.75%
18,900 $859,000
Q4 2017

Feb 15, 2018

SELL
$57.69 - $84.58 $63,459 - $93,038
-1,100 Reduced 8.94%
11,200 $762,000
Q3 2017

Nov 14, 2017

BUY
$67.17 - $84.81 $826,191 - $1.04 Million
12,300
12,300 $1.01 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.